News CanCertainty Coalition Applauds The Ontario PC Party’s Commitment To Equality For Cancer Patients CanCertainty Coalition Applauds The Ontario PC Party's Commitment To Equality For Cancer Patients – The…adminNovember 27, 2017
News Obinutuzumab Reduces Risk of Disease Progression in Follicular Lymphoma Obinutuzumab Reduces Risk of Disease Progression in Follicular Lymphoma Interim analysis of the GALLIUM (NCT01332968)…adminOctober 19, 2017
EventsNews Spaghetti sauce for lymphoma Nick was diagnosed with non Hodgkin's Lymphoma in September 2013. Once treated and in remission,…adminOctober 2, 2017
News CANCER PATIENTS CELEBRATE NEW PROGRAM FOR TAKE-HOME CANCER MEDICATIONS IN NOVA SCOTIA CANCER PATIENTS CELEBRATE NEW PROGRAM FOR TAKE-HOME CANCER MEDICATIONS IN NOVA SCOTIA -- Province’s investment…adminSeptember 27, 2017
News Hodgkin Lymphoma Patient Survey: Experience with Nivolumab (Opdivo) Hodgkin Lymphoma Patient Survey: Experience with Nivolumab (Opdivo) If you have or had Hodgkin lymphoma…adminSeptember 19, 2017
EventsNews Count Down to World Lymphoma Awareness Day #EverythingChanges for World Lymphoma Awareness Day No one ever expects to sit in the doctor’s…adminSeptember 6, 2017
News Hodgkin Lymphoma Patient Survey: Experience with Brentuximab-vedotin (Adcetris) Hodgkin Lymphoma Patient Survey: Experience with Brentuximab-vedotin (Adcetris) If you have or had Hodgkin lymphoma…adminJuly 26, 2017
News Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin Lymphoma at Increased Risk of Relapse or Progression Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin…adminJuly 26, 2017
EventsNews Lymphoma Canada Awareness Day at Queen’s Park Lymphoma Canada Awareness Day at Queen's Park Cocktail reception 5:00 p.m. – 7:00 p.m. Guests must…adminJuly 19, 2017
News New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients Treatment with a new targeted therapy, duvelisib, has shown sustained efficacy and safety in a…adminJuly 7, 2017